Cytotoxic 4'-aminochalcones and related compounds.
Article 2003 en
Authors
JD
J.R. Dimmock
AJ
Amitabh Jha
GZ
Gordon A. Zello
Abstract
1 min read
A series of 4'-aminochalcones 1 and related maleamic acids 2 and Schiff bases 3 were designed and synthesized as candidate cytotoxic agents. The atomic charges on different atoms of representative compounds were calculated. Evaluation of the enones 1-3 against human Molt 4/C8 and CEM T-lymphocytes as well as murine P388 and L1210 leukemic cells revealed that approximately 40% of the IC50 values generated were less than 10 microM. In some cases cytotoxicity was correlated with the Hammett sigma values of the aryl substituents and less frequently with the aryl Hansch pi values. Evidence was obtained that in general these compounds displayed selective toxicity for certain malignant cells and were well tolerated in mice. This study has revealed various directions whereby the project may be amplified in the future with a view to finding compounds with increased cytotoxicity to tumour cells.
Jonathan R. Dimmock, N. Murthi Kandepu, Mark Hetherington, J. Wilson Quail, U. Pugazhenthi, Athena Sudom, Mahmood Chamankhah, Patricia A. Rose, Eric W. Pass, Theresa M. Allen, S. Halleran, Jen Szydlowski, Bülent Mutus, Marie Tannous, Elias K. Manavathu, Timothy G. Myers, De Clercq Erik, Jan Balzarini
Jonathan R. Dimmock, Maniyan P. Padmanilayam, R.N. Puthucode, Adil J. Nazarali, Narasimhan L. Motaganahalli, Gordon A. Zello, J. Wilson Quail, E.O. Oloo, Heinz‐Bernhard Kraatz, Jared S. Prisciak, Theresa M. Allen, C.L. Santos, Jan Balzarini, De Clercq Erik, Elias K. Manavathu
Jonathan R. Dimmock, Amitabh Jha, Gordon A. Zello, Rajendra K. Sharma, Anuraag Shrivastav, Selvakumar Palaniappan, Theresa M. Allen, C.L. Santos, Jan Balzarini, De Clercq Erik, Elias K. Manavathu, James P. Stables
J.R. Dimmock, Mahmood Chamankhah, Umashankar Das, Gordon A. Zello, J. Wilson Quail, Jinliang Yang, Kurt H. Nienaber, Rajendra K. Sharma, Selvakumar Palaniappan, Jan Balzarini, De Clercq Erik, James P. Stables
Discussion(0)
No comments yet. Be the first to comment.